Olympic champion Peres Jepchirchir tests positive for EPO, provisionally suspended by Athletics Integrity Unit

Peres Jepchirchir, the Olympic and World Championships marathon gold medallist, has been provisionally suspended by the Athletics Integrity Unit (AIU) after an out-of-competition sample returned an adverse analytical finding for erythropoietin (EPO). The 33-year-old Kenyan provided the sample before winning the Sydney Marathon on 30 August 2026, the race she took in two hours, 18 minutes and 31 seconds. According to the notice issued by the AIU, the sample was collected in Kenya ahead of the competition, meaning it was taken while Jepchirchir was training at home in the build-up to Sydney. The AIU has the authority to impose a provisional suspension either when a prohibited substance or its metabolites are detected in a sample, or when there is other evidence of a breach of the athletics integrity rules. A provisional suspension bars an athlete from competing until a final decision is reached, and that decision can later be overturned at a full hearing. The news is a significant blow to the top tier of women's marathon running, where Jepchirchir has been the standout performer of the past five years. She has won Olympic gold, a world title and four major city marathons. The allegation arrives shortly after her latest big victory, a race she won by more than three minutes. In Sydney, Jepchirchir finished more than three minutes clear of her compatriot Irene Chepet Cheptai. The race became the seventh Abbott World Marathon Major in 2026, joining the established group of Boston, New York, London, Berlin, Chicago and Tokyo. The victory in Sydney therefore carried added weight, because the race is now assessed on the same international footing as the other majors. EPO, or erythropoietin, is a natural substance produced within the kidneys that stimulates the creation of new red blood cells. If injected, it is only detectable in urine or blood for a short window of time, and it increases the number of red blood cells, which carry oxygen to the muscles, in the bloodstream. That is precisely why EPO is regarded as one of the most potent and most contested performance-enhancing substances in sport. Its abuse has been a serious problem in endurance disciplines for decades, and detection is complicated by the fact that the substance occurs naturally in the body. Investigators must establish whether the quantity found falls outside natural limits, drawing on paired blood and urine samples and on data from the athlete's biological passport. A provisional suspension does not mean guilt has been established. It is a procedural step used by the AIU to protect the integrity of competition while an investigation continues, so that an accused athlete cannot compete in the interim. Under the rules, the athlete retains a full right of defence. She can request that the B sample be analysed, and she can present medical documentation or other evidence. If the B sample also confirms the finding, the case proceeds to a disciplinary panel. EPO sits in the category of substances classified as non-specified. For a first offence in this category, the standard sanction is four years, although the rules allow the period to be reduced or increased depending on the circumstances. If the violation is found to have been intentional, the sanction can be extended. If an athlete can establish that she bore no fault or negligence, the period can be reduced. Cases of this kind frequently take many months to resolve. Jepchirchir's career has been one of the most compelling stories in Kenyan distance running over the past decade. She came up through the half marathon and made the transition to the full distance. In 2026 she broke the women's half-marathon world record, and in 2026 she broke or equalled it on three further occasions. That capacity to produce fast times consistently on the roads is what set her apart from her peers. After her success over 21.1 kilometres, she turned her attention to the marathon. At the Tokyo Olympics, held in 2026, she won the women's marathon gold. That race is remembered for brutal heat and humidity, and on the day several big names dropped away early. Jepchirchir balanced pace and discipline so well that she moved clear in the closing stages. It remains the defining result of her career. Later that same year she won the New York City Marathon. New York is known for its undulating roads and its bridges, and winning there on a first attempt is notoriously difficult. Coming just months after Olympic gold, the victory was read as proof of her mental resilience. In 2026 she won the Boston Marathon. The Boston course is famous for its hills and its changing gradients, and there is no easy route to victory there. With that win she joined the select group of women who have won an Olympic title, New York and Boston. In 2026 she added the London Marathon title. London routinely assembles the strongest women's marathon field in the world, and victory there is generally taken as evidence that an athlete remains at the very top of the discipline. Those four major wins established her as the leading women's marathon runner of her generation. In September 2026 Jepchirchir returned to Tokyo and won the World Championships title. That was a notable achievement because it meant winning Olympic gold and then a world title in the same city five years apart. A world championship marathon is difficult in its own way, because athletes compete for their countries and the field often brings together the most experienced runners in the sport. The question now is what the suspension means for her medals. The rules generally confine a provisional suspension to the period before the case is resolved. It is also not yet clear whether any earlier sample or earlier result will be affected. Experts typically note that where a sample taken at a race returns an adverse finding, the title and prize money from that race can also be withdrawn, but that depends on the final ruling. One point that is repeated in sports reporting is that EPO cases are usually treated as among the most serious, because they point to a deliberate intent to enhance performance. Jepchirchir's case is particularly sensitive because she is Kenyan, and Kenya has long been a focal point of anti-doping scrutiny in endurance sport. Several Kenyan distance runners have been banned in recent years, and the country's athletics system has faced repeated questions as a result. That context makes the role of the AIU important. The unit operates independently of World Athletics and oversees anti-doping enforcement internationally. Its core task is to protect the credibility of the sport and to ensure that the rules apply equally to everyone. A provisional suspension is part of that framework, intended to preserve fairness while an investigation runs. Within women's marathon running, Jepchirchir has been the most recognisable face of the sport in recent years. Her running style, her ability to accelerate over the final kilometres and her knack for holding form in difficult conditions such as heat are what make her distinctive. Several major races built their identity around her presence, and her participation is now in question. For sponsors and organisers, the situation is awkward. Major marathons rely on elite names as their central draw for spectators and broadcasters. When a leading athlete is under investigation, organisers must promote a race without her name at the front of it. Commercially this is a difficult equation, because the sport's market rests on trust. From the athlete's perspective, the rules provide meaningful avenues of defence. An appeal to the Court of Arbitration for Sport, analysis of the B sample, a claim of a therapeutic use exemption or an allegation of a procedural error in sample collection are all potential routes. In EPO cases, however, such defences are not straightforward, because the analytical method is considered robust and cases normally proceed only after confirmation in both samples. It also matters that the sample was collected before the competition. That means the testing process began before the race, and the suspension was announced afterwards. The sequence means the Sydney result can now be viewed within the scope of the same investigation, although no formal decision on that point has been made public. Jepchirchir's list of achievements is long. Olympic gold, a world championship title, a world record, and victories in New York, Boston, London and Sydney together form a record that very few runners have managed. If the case against her is established, that list will remain on paper, but its lustre will be questioned. The case will also have a wider effect on the sport's governance. When a major name falls under anti-doping scrutiny, the debate turns to how effective the testing system really is. Some argue it demonstrates that testing works, because athletes at the very top are being caught. Others ask how, if a runner of this stature returned an adverse finding, the testing process and the culture of the sport need to change. In the next stage, the AIU must decide whether the case goes before a disciplinary panel, and the panel must set a period based on the evidence. In the meantime, the athlete's representatives can argue that there were procedural flaws in testing, or that the collection and transport of the sample did not follow the rules. Such arguments often produce lengthy hearings. The case is also a reminder of how old and how complex the doping challenge in endurance sport is. The marathon is a discipline in which the limits of the body decide the outcome, which is exactly why substances that increase oxygen-carrying capacity are so tempting. Investigators are fighting that temptation. For Jepchirchir's supporters, this is a difficult moment. What she did in the heat of Tokyo, over the bridges of New York, up the hills of Boston and along the streets of London is part of the sport's history. But the credibility of the sport depends on every question being answered through a fair process. The conclusion is that the case remains at an early stage. A provisional suspension is part of a process, not a final verdict. But it has already made one thing clear: anti-doping enforcement in world athletics is moving faster and looking harder, and what emerges at the hearing, and how the sport handles it, is still to be seen.